Home › Funds › GRIMES & Co WEALTH MANAGEMENT, LLC › ABBV

GRIMES & Co WEALTH MANAGEMENT, LLC position in ABBV

ABBVIE INC · Health Care

GRIMES & Co WEALTH MANAGEMENT, LLC reported holding 104,631 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$27.4M, representing 0.64% of its reported portfolio and ranking #33 among its reported holdings. GRIMES & Co WEALTH MANAGEMENT, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)104.63K sh
Reported value held$27.37M
Portfolio Weight0.64%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GRIMES & Co WEALTH MANAGEMENT, LLC's ABBV position evolved

GRIMES & Co WEALTH MANAGEMENT, LLC first disclosed a stake in ABBV in Q3 2023 at 95,110 shares (US$14.2M). The position peaked in Q3 2026 at 104,631 shares, worth US$27.4M. Across 13 filings, GRIMES & Co WEALTH MANAGEMENT, LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 104,631 shares valued at US$27.4M — an increase of 997 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 95.11K $14.18M New
Q4 2023 99.36K $15.40M Add
Q1 2024 100.24K $18.25M Add
Q2 2024 100.57K $17.25M Hold
Q3 2024 101.61K $20.07M Add
Q4 2024 102.25K $18.17M Add
Q1 2025 103.11K $21.60M Add
Q2 2025 105.28K $19.54M Add
Q3 2025 106.99K $24.77M Add
Q4 2025 109.21K $24.95M Add
Q1 2026 109.82K $23.88M Add
Q2 2026 103.63K $26.08M Reduce
Q3 2026 104.63K $27.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has GRIMES & Co WEALTH MANAGEMENT, LLC held ABBV?

GRIMES & Co WEALTH MANAGEMENT, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GRIMES & Co WEALTH MANAGEMENT, LLC's current position in ABBV?

As of Q3 2026, GRIMES & Co WEALTH MANAGEMENT, LLC holds 104.63K shares of ABBV (ABBVIE INC), valued at $27.37M, representing 0.64% of its reported portfolio and ranking #33.

Has GRIMES & Co WEALTH MANAGEMENT, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), GRIMES & Co WEALTH MANAGEMENT, LLC increased its position in ABBV. The position peaked in Q3 2026 at 104.63K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.